Artwork

内容由Bell Direct提供。所有播客内容(包括剧集、图形和播客描述)均由 Bell Direct 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

From the helm: Cyclopharm's (ASX:CYC) MD & CEO, James McBrayer

5:57
 
分享
 

Manage episode 284144805 series 2611018
内容由Bell Direct提供。所有播客内容(包括剧集、图形和播客描述)均由 Bell Direct 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this instalment of our From the helm series, Bell Direct’s Jessica Amir speaks to Cyclopharm's (ASX:CYC) MD & CEO, James McBrayer.
Cyclopharm is a little known Aussie company. Its medical technology is used in 60 countries around the world to help doctors identify lung capacity, as well as find potential blood clots. With earnings mostly coming from Europe, CYC's US journey gathers momentum with USFDA approval looming. The US is home to the world's largest nuclear medicine market.
In this video James discusses:
- (0:31) What CYC does & its "imminent" entry into the US
- (1:11) Key catalysts to drive share price growth
- (1:47) Commercialising the product in the US
- (2:46) CYC's product being endorsed to help fight COVID-19 in the US
- (3:31) How the company has reduced its risks
- (4:56) After a 110% rise in share price last year, what can investors expect for the year ahead?

  continue reading

57集单集

Artwork
icon分享
 
Manage episode 284144805 series 2611018
内容由Bell Direct提供。所有播客内容(包括剧集、图形和播客描述)均由 Bell Direct 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this instalment of our From the helm series, Bell Direct’s Jessica Amir speaks to Cyclopharm's (ASX:CYC) MD & CEO, James McBrayer.
Cyclopharm is a little known Aussie company. Its medical technology is used in 60 countries around the world to help doctors identify lung capacity, as well as find potential blood clots. With earnings mostly coming from Europe, CYC's US journey gathers momentum with USFDA approval looming. The US is home to the world's largest nuclear medicine market.
In this video James discusses:
- (0:31) What CYC does & its "imminent" entry into the US
- (1:11) Key catalysts to drive share price growth
- (1:47) Commercialising the product in the US
- (2:46) CYC's product being endorsed to help fight COVID-19 in the US
- (3:31) How the company has reduced its risks
- (4:56) After a 110% rise in share price last year, what can investors expect for the year ahead?

  continue reading

57集单集

Tất cả các tập

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南